From the bench to the boardroom
News from the Buck and beyond
Buck researchers weigh in on why women are more likely to develop Alzheimer’s disease
A team from China has identified a reproductive hormone that may play a key role in boosting susceptibility for Alzheimer’s in women...
Healthy aging starts in our cells – and in the places where we live!
Healthy aging starts in our cells and in the communities where we live! In this blog we explore the Age-Friendly movement which is focused on making communities livable for people of all ages...
We’re excited about single-cell sequencing technology and think you should be too!
Professor Simon Melov is championing the use of single cell sequencing – calling it the biggest technological revolution in biology in the last 30 years...
Buck professor Julie Andersen weighs in on Aduhelm, the controversial Alzheimer’s drug
The promise of Metformin highlights the need for precision medicine
Metformin became a “darling” of research on aging when medical records revealed that people with diabetes taking the drug often lived longer, healthier lives.
Old Dogs, New Tricks: New Roles for FGF21, a Well-Known Metabolic Molecule
Mitochondrial Ubiquinol Oxidation: Could this be the answer to stop tumor growth in its path?
Understanding the role mitochondrial metabolism in tumor growth.
Making Research Fair and Equitable
Read up on racial disparities in clinical trials and steps we can take to make sure that gains in healthspan are shared equally.
Healthcare Around the World: Costs, Covid, and Comparisons
How do different healthcare systems respond to pandemic? Here is a summary of the real-world experiment that has been happening over the past year.